#USA #New York #Securities Fraud #Rosen Law Firm #ModivCare

ModivCare Securities Fraud Lawsuit: Important Update for Investors

As of March 26, 2025, investors in ModivCare Inc. (NASDAQ: MODV) have been alerted by Rosen Law Firm, a leading global investor rights firm, regarding an essential deadline to participate in a securities fraud class action. This notice is pertinent for those who purchased shares of ModivCare between November 3, 2022, and September 15, 2024, inclusive. Investors must act by March 31, 2025, to secure their position as potential lead plaintiffs in this case.

Rosen Law Firm emphasizes that participants in the class action do not bear any out-of-pocket expenses due to a contingency fee arrangement. This means that if successful, the payout will cover any legal fees, making it easier for investors to seek justice without financial barriers.

What’s Happening?

This class action lawsuit stems from allegations that ModivCare’s executives made misleading statements and concealed detrimental facts regarding the company’s performance and prospects. It is claimed that vital issues regarding contracts in ModivCare's non-emergency medical transportation (NEMT) segment significantly deteriorated the company's financial standing. Key points mentioned in the lawsuit include:

• - Material Misstatements: The defendants allegedly made false statements regarding ModivCare's operational efficiency and market position, which later turned out to be unfounded.
• - Capital Deterioration: The contracts that ModivCare relied upon led to a significant decline in free cash flow, which in turn impacted the company's adjusted EBITDA and liquidity.
• - Investors Affected: When these truths began to surface, many investors reportedly incurred significant financial damages as a result of their investments.

How to Participate

Investors who purchased ModivCare securities during the specified class period can become involved by visiting the Rosen Law Firm’s dedicated webpage or contacting Phillip Kim, Esq. at 866-767-3653. Additional information on joining the class action can also be obtained via email at [email protected]. It is crucial for interested investors to take action before the March 31 deadline, as leadership roles in these lawsuits are often pivotal in guiding litigation direction.

Selecting the Right Legal Counsel

With various firms vying for representation, Rosen Law Firm underscores the importance of selecting a counsel with an established history of success in securities class actions. Many law firms merely act as intermediaries without the necessary litigation experience, further highlighting the need for investors to choose wisely.

Notably, Rosen Law Firm has achieved record recoveries for investors, including large settlements in notable cases involving securities class actions. Over the years, the firm has consistently been recognized for its leadership and efficiency in navigating complex securities litigation, making them a recommended choice for those affected by the ModivCare situation.

Conclusion

For ModivCare investors, this impending deadline signifies a crucial opportunity to seek recourse and potentially recover damages from alleged securities fraud. The emphasis on no upfront costs should encourage more investors to step forward and join the class action. As awareness grows about this lawsuit, investors must act decisively to protect their rights and ensure they have a voice in this important legal matter.